Activities per year
Activities
- 37 results
Search results
-
American College of Cardiology Annual Meeting (Journal)
Lisette Okkels Jensen (Editor)
2013 → …Activity: Editorial work and peer review › Peer review of manuscripts › Research
-
Transcatheter Cardiovascular Therapeutics
Lisette Okkels Jensen (Participant)
22. Oct 2012 → 26. Oct 2012Activity: Attending an event › Organisation or participation in workshops, courses or seminars
-
Transcatheter Cardiovascular Therapeutics
Lisette Okkels Jensen (Participant)
22. Oct 2012 → 26. Dec 2012Activity: Attending an event › Organisation or participation in workshops, courses or seminars
-
Moderate Obesity is Beneficial and Severe Obesity Detrimental for Patients with Documented Atherosclerotic Heart Disease
Lisette Okkels Jensen (Other)
25. Aug 2012 → 29. Aug 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
EURO
Lisette Okkels Jensen (Participant)
17. May 2012Activity: Attending an event › Organisation or participation in workshops, courses or seminars
-
Randomized comaprison of the biolimus-eluting biodegradable polymer coated Nobori stent and the durable polymer coated sirolimus-eluting Cypher Select+ stent in unselected patients treated with percutaneous coronary intervention. The SORT OUT V Trial.
Lisette Okkels Jensen (Lecturer)
17. May 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Immediate Mobilization after Coronary Angiography Following Hemostasis with the AngioSeal Vascular Closure Device
Lisette Okkels Jensen (Other)
16. May 2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Is Same-Day Discharge after Uncomplicated Percutaneous Coronary Intervention with Femoral Access Safe?
Lisette Okkels Jensen (Other)
16. May 2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Should all STEMI patiens routinely be treated with thrombus aspiration?
Lisette Okkels Jensen (Lecturer)
16. May 2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
American College of Cardiology
Lisette Okkels Jensen (Speaker)
24. Mar 2012 → 26. Mar 2012Activity: Talks and presentations › Conference presentations
-
Mechanisms and Findings in Restenosis and Early Stent Thomrbosis: IVUS, VH-IVUS, OCT, Spectroscopy and Beyond.
Lisette Okkels Jensen (Lecturer)
24. Mar 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
American College of Cardiology
Lisette Okkels Jensen (Participant)
2012 → …Activity: Attending an event › Conference organisation or participation
-
Definite and Probable Stent Thrombosis after Revascularization with Everolimus- and Sirolimus-Eluting Stents.
Lisette Okkels Jensen (Lecturer)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Demensions of Socioeconomic Status and Clinical Outcome After Primary Percutaneous Coronary Intervention.
Lisette Okkels Jensen (Lecturer)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
EuroPCR (Journal)
Lisette Okkels Jensen (Editor)
2012 → …Activity: Editorial work and peer review › Peer review of manuscripts › Research
-
Impact of Lesion Length on Outcomes After Revascularization with Everolimus- and Sirolimus Eluting stents.: A Substudy of the SORT OUT IV Trial.
Lisette Okkels Jensen (Other)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Influence of Single-Vessel Disease or Multi-Vessel Disease with or without further Revascularization on Mortality.
Lisette Okkels Jensen (Speaker)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Influence of Single-Vessel Disease or Multi-Vessel Disease with or without further Revascularization on Mortality.
Lisette Okkels Jensen (Lecturer)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Long-term Outcome after Percutaneous Coronary Intervention with Drug-Eluting Stents Compared to Bare-Metal Stents in Saphenous Vein Graft Lesions. From Western Denmark Heart Registry.
Lisette Okkels Jensen (Speaker)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Longterm Outcome after Percutaneuos Coronary Intervention with Drug-Eluting Stents Compared to Bare-Metal Stents in Saphenous Vein Graft Lesions.
Lisette Okkels Jensen (Lecturer)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Moderate obesity is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease.
Lisette Okkels Jensen (Speaker)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Small and Large Coronary Arteries.: A substudy of the SORT OUT IV Trial
Lisette Okkels Jensen (Participant)
2012 → …Activity: Other activities › Other
-
Prospective, Randomized Trian of N-Acetyl Cysteine and Sodium Bicarbonate In Patients with ST-Segment Elevation Myocardial Infarction.
Lisette Okkels Jensen (Speaker)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Prospective Randomized Trial of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease (SORT OUT IV trial) - 3-year follow up.
Lisette Okkels Jensen (Speaker)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Rates of and risks associated with discontinuation of clopidogrel treatment within the first year after coronary stent implantation in Western Denmark.
Lisette Okkels Jensen (Lecturer)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Two-year Patient-related Versus Stent-related Outcomes From The SORT OUT IV Trial.
Lisette Okkels Jensen (Other)
2012 → …Activity: Talks and presentations › Talks and presentations in private or public companies
-
Transcatheter Cardiovascular Therapeutics TCT (Journal)
Lisette Okkels Jensen (Editor)
2012 → …Activity: Editorial work and peer review › Peer review of manuscripts › Research
-
Randomised comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention
Lisette Okkels Jensen (Lecturer)
Sep 2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Clinical presentation of angiographic confirmed stent thrombosis and in-stent restenosis in patients with bare metal or drug-eluting stents: From Western Denmark Heart Registry
Lisette Okkels Jensen (Lecturer)
2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Incidence of secondary definite stent thrombosis or in-stent restenosis after target vessel revascularization: From Western Denmark Heart Registry
Lisette Okkels Jensen (Lecturer)
2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Three-year clinical outcome following primary percutaneous coronary intervention in diabetic and non-diabetic patients with ST-segment elevation myocardial infarction
Lisette Okkels Jensen (Lecturer)
2010Activity: Talks and presentations › Talks and presentations in private or public companies
-
Optimising stent deployment: Insight from IVUS
Lisette Okkels Jensen (Lecturer)
14. May 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Intravaskulær Ultralydsdiagnostik.: Regression af aterosklerose.
Lisette Okkels Jensen (Lecturer)
22. Apr 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
PCI og drug-eluting stents diabetikere vs. non-diabetikere.: Komplikationer ved hyperkolesterolæmi, ny teknologi og kliniske vejledere
Lisette Okkels Jensen (Lecturer)
15. Apr 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
The drug eluting stent controversy: How safe are stents today and how safe will they be tomorrow? (including the evolving role of antiplatelet therapy)
Lisette Okkels Jensen (Lecturer)
10. Apr 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Nordic PCI 2008 drug-eluting stents - when to use intravascular ultrasound
Lisette Okkels Jensen (Lecturer)
20. Jan 2008Activity: Talks and presentations › Talks and presentations in private or public companies
-
Intravascular Ultrasound Assessment of Remodelling after Drug Eluting Stents in Diabetic Patients
Lisette Okkels Jensen (Speaker)
11. Mar 2007 → 16. Mar 2007Activity: Talks and presentations › Talks and presentations in private or public companies